Limits of Negative Infection Studies in AD - Takeaways - MDSpire

Limits of Negative Infection Studies in AD

Perspective argues that study design and measurement challenges may obscure potential links between infection and disease

  • By

  • Kerri Miller

  • March 26, 2026

  • 2 min

Share

  • 1

    Negative infection studies in Alzheimer's disease may misinterpret data due to poor alignment with research questions.

  • 2

    Serum antibody titers do not accurately reflect central nervous system infections, complicating study outcomes.

  • 3

    Electronic health records may overlook milder infections, leading to incomplete data on pathogen exposure.

  • 4

    Genetic factors, such as APOE ε4, may influence the relationship between pathogens and Alzheimer's risk.

  • 5

    The authors advocate for refined study designs that incorporate genetic context and infection dynamics.

Original Source(s)

Limits of Negative Infection Studies in AD

  • by Kerri Miller

  • March 26, 2026

Related Content

Hospital Admission May Raise Health Care Spending in Dementia

Quasi-experimental analysis of nearly 900,000 emergency department visits found no evidence of lower mortality among admitted patients.

Side Effects: Context Is the Diagnosis

This week's research makes one thing clear: who someone is before they get sick — their relationships, their partner's health, the back of their eye — is doing a lot of work medicine is only beginning to account for.

Acupuncture for Neuroinfections?

A recent Perspective offered a speculative mechanistic argument for acupuncture’s potential role as an adjunctive strategy in neuroinfectious diseases.